Medanta, the leading private healthcare provider, reported a solid Q4 FY25 with total income up 14% year-on-year at INR 9,542 million and EBITDA rising 20% to INR 2,476 million, showcasing healthy margins of 26%. The company declared its first-ever dividend of 25% (INR 0.50 per share), signaling robust financial health and shareholder confidence. For the full year, total revenue grew 12.6% to INR 37,714 million, with EBITDA at INR 9,562 million and adjusted PAT at INR 5,186 million.
Medanta’s aggressive bed capacity expansion continues, adding 219 beds in FY25 and planning a 550-bed facility in Noida by Q2 FY26. Projects in Mumbai, Pitampura, Ranchi, and Guwahati are on track to enhance its national footprint.
The demand for advanced healthcare services is rising steadily. Medanta’s expansion into Guwahati is strategically positioned to serve patients from Tripura and neighboring states, tapping into the underserved Northeast healthcare market. Local businesses and patients anticipate improved access to quality care, fueling optimism for sector growth in the region.
